nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—ABCB1—Lisinopril—dilated cardiomyopathy	0.344	0.532	CbGbCtD
Triflupromazine—ABCB1—Spironolactone—dilated cardiomyopathy	0.303	0.468	CbGbCtD
Triflupromazine—HTR2B—cardial valve—dilated cardiomyopathy	0.1	0.786	CbGeAlD
Triflupromazine—Moricizine—SCN5A—dilated cardiomyopathy	0.0149	0.537	CrCbGaD
Triflupromazine—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.00836	0.301	CrCbGaD
Triflupromazine—BCHE—cardiac ventricle—dilated cardiomyopathy	0.0062	0.0486	CbGeAlD
Triflupromazine—CHRM2—heart—dilated cardiomyopathy	0.00612	0.048	CbGeAlD
Triflupromazine—HTR2B—heart—dilated cardiomyopathy	0.00554	0.0434	CbGeAlD
Triflupromazine—BCHE—heart—dilated cardiomyopathy	0.00407	0.0319	CbGeAlD
Triflupromazine—BCHE—cardiac atrium—dilated cardiomyopathy	0.00348	0.0273	CbGeAlD
Triflupromazine—Desipramine—SLC22A5—dilated cardiomyopathy	0.00199	0.0716	CrCbGaD
Triflupromazine—ABCB1—heart—dilated cardiomyopathy	0.00194	0.0152	CbGeAlD
Triflupromazine—Desipramine—ADRB1—dilated cardiomyopathy	0.00137	0.0494	CrCbGaD
Triflupromazine—Desipramine—ADRB2—dilated cardiomyopathy	0.00116	0.0416	CrCbGaD
Triflupromazine—HTR2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00047	0.00238	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000458	0.00232	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.000457	0.00231	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000454	0.0023	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000444	0.00225	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000443	0.00224	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00044	0.00222	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000439	0.00222	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000438	0.00222	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00043	0.00218	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—TAZ—dilated cardiomyopathy	0.00043	0.00217	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000429	0.00217	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000425	0.00215	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000423	0.00214	CbGpPWpGaD
Triflupromazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000416	0.0021	CbGpPWpGaD
Triflupromazine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000407	0.00206	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000402	0.00203	CbGpPWpGaD
Triflupromazine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000402	0.00203	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000402	0.00203	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000393	0.00199	CbGpPWpGaD
Triflupromazine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00039	0.00197	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—SDHA—dilated cardiomyopathy	0.000389	0.00196	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000381	0.00193	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000379	0.00191	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000376	0.0019	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000372	0.00188	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000372	0.00188	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000371	0.00188	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000368	0.00186	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000364	0.00184	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000364	0.00184	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000363	0.00183	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000359	0.00182	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000359	0.00182	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000359	0.00182	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000356	0.0018	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00035	0.00177	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000349	0.00177	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000349	0.00176	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000348	0.00176	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000346	0.00175	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000344	0.00174	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000339	0.00172	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000338	0.00171	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000335	0.00169	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000334	0.00169	CbGpPWpGaD
Triflupromazine—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000333	0.00168	CbGpPWpGaD
Triflupromazine—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000332	0.00168	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00033	0.00167	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00033	0.00167	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000328	0.00166	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000328	0.00166	CbGpPWpGaD
Triflupromazine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000325	0.00164	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000323	0.00164	CbGpPWpGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000321	0.00162	CbGpPWpGaD
Triflupromazine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000321	0.00162	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000307	0.00155	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000295	0.00149	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000295	0.00149	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000286	0.00145	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000283	0.00143	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000283	0.00143	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00028	0.00141	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000278	0.00141	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000278	0.00141	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000276	0.0014	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000274	0.00139	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000271	0.00137	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000269	0.00136	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000268	0.00136	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000268	0.00136	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000267	0.00135	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000266	0.00134	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000266	0.00134	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000264	0.00134	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000262	0.00133	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000259	0.00131	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000259	0.00131	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000259	0.00131	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000255	0.00129	CbGpPWpGaD
Triflupromazine—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	0.000255	0.00129	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000254	0.00129	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000253	0.00128	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000253	0.00128	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000251	0.00127	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000249	0.00126	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000242	0.00123	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000241	0.00122	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000239	0.00121	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000237	0.0012	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000235	0.00119	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000231	0.00117	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000228	0.00115	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000227	0.00115	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000223	0.00113	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000223	0.00113	CbGpPWpGaD
Triflupromazine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000223	0.00113	CbGpPWpGaD
Triflupromazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00022	0.00111	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000215	0.00109	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000214	0.00108	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00021	0.00106	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00021	0.00106	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.00021	0.00106	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000208	0.00105	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000206	0.00104	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000206	0.00104	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000206	0.00104	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000203	0.00103	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000203	0.00103	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000203	0.00103	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000202	0.00102	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000201	0.00102	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000197	0.000996	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000196	0.000989	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000195	0.000988	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000194	0.000983	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000194	0.000983	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000191	0.000967	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000191	0.000965	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000191	0.000965	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.00019	0.000959	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000189	0.000957	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000189	0.000954	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000187	0.000944	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000187	0.000944	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000185	0.000936	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000184	0.000932	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000184	0.000932	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000184	0.000932	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000183	0.000924	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	0.00018	0.000908	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000178	0.000902	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000177	0.000897	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000174	0.000878	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000172	0.000869	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000171	0.000867	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000169	0.000852	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000168	0.00085	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000168	0.00085	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000167	0.000845	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000166	0.00084	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000166	0.000839	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000162	0.000817	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00016	0.000807	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000158	0.000801	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000158	0.000801	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000158	0.0008	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000158	0.000797	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000156	0.000789	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000153	0.000775	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000152	0.000767	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000151	0.000762	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00015	0.000759	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000149	0.000755	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000149	0.000755	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000148	0.000749	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000147	0.000744	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000147	0.000742	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000145	0.000733	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000144	0.000726	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000143	0.000724	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000143	0.000721	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000142	0.000717	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000139	0.000704	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000139	0.000702	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000137	0.000692	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000136	0.000689	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000134	0.00068	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000134	0.00068	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000127	0.000642	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000124	0.000628	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000123	0.00062	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000122	0.000616	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000119	0.000602	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000116	0.000589	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000116	0.000584	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000116	0.000584	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000115	0.000581	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000115	0.000581	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000114	0.000575	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000113	0.00057	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000113	0.00057	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000111	0.000563	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00011	0.000558	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00011	0.000558	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00011	0.000556	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00011	0.000555	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000109	0.000551	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000109	0.000551	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000109	0.000551	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000108	0.000546	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000106	0.000535	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GPX1—dilated cardiomyopathy	0.000106	0.000534	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000105	0.00053	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000104	0.000528	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000103	0.000522	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CD36—dilated cardiomyopathy	0.000103	0.00052	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000103	0.000519	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000102	0.000513	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000101	0.000512	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000101	0.000511	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000101	0.000509	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	9.98e-05	0.000504	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.93e-05	0.000502	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.93e-05	0.000502	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.81e-05	0.000496	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.49e-05	0.00048	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.36e-05	0.000473	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AGT—dilated cardiomyopathy	9.26e-05	0.000468	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	8.97e-05	0.000453	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.67e-05	0.000438	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	8.57e-05	0.000433	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.48e-05	0.000429	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	8.46e-05	0.000428	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.38e-05	0.000423	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.22e-05	0.000416	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	8.08e-05	0.000409	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.05e-05	0.000407	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.95e-05	0.000402	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.17e-05	0.000362	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.07e-05	0.000357	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.01e-05	0.000355	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.92e-05	0.00035	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.92e-05	0.00035	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.9e-05	0.000349	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.83e-05	0.000345	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.69e-05	0.000338	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.51e-05	0.000329	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.38e-05	0.000323	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.25e-05	0.000316	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.17e-05	0.000312	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	6.1e-05	0.000308	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	5.97e-05	0.000302	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	5.95e-05	0.000301	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	5.89e-05	0.000298	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.61e-05	0.000284	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	5.15e-05	0.00026	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	5.02e-05	0.000254	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.91e-05	0.000248	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.81e-05	0.000243	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.75e-05	0.00024	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.52e-05	0.000228	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.23e-05	0.000214	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.14e-05	0.000209	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.09e-05	0.000207	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	4.08e-05	0.000206	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.85e-05	0.000194	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.9e-05	0.000147	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.84e-05	0.000144	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.8e-05	0.000142	CbGpPWpGaD
